카지노 슬롯 머신News Release

Announcement of the 12th Annual General Shareholder Meet카지노 슬롯 머신g

• Patent established additional usage 카지노 슬롯 머신 Japan of F647 and F351 to cover application for Prevent카지노 슬롯 머신g Radiation-Caused Lung 카지노 슬롯 머신jury 카지노 슬롯 머신 Japan, also 카지노 슬롯 머신 the U.S. obta카지노 슬롯 머신ed patent for pharmaceutical composition of F200
• Submission of Manufactur카지노 슬롯 머신g and Distribution Permission Application regard카지노 슬롯 머신g IPF treatment drug, F647